The GENESIS Pregnancy Registry

Have you been diagnosed with migraine? Are you currently pregnant? Have you taken Aimovig® (erenumab-aooe) shortly before or during pregnancy? If so, you may be able to take part in a United States pregnancy registry.

This registry has been created to help doctors better understand if Aimovig has any effect on a woman’s pregnancy, delivery, or baby. However, you do not have to have taken Aimovig to participate.

If you are currently pregnant and taking Aimovig® (erenumab-aooe), contact your healthcare provider. They will decide if you should stop taking Aimovig®.

Get more info on the registry

How do I participate?

Fill out the contact form to have a registry representative contact you with more information about this pregnancy registry.

Call the registry’s toll-free number
1-(833)-244-4083 and speak to a registry representative.

Ask your healthcare provider to help you complete the contact form.

About pregnancy and pregnancy registries

Many pregnant women take medication during pregnancy. Pregnancy registries are studies that follow women who take medication knowingly during pregnancy or before they knew they were pregnant. These studies are a chance to gather vital information about the effects of drugs or treatments on pregnancies and newborns’ health.

Pregnancy registries are the primary way healthcare providers can learn about important safety information.

By enrolling in a pregnancy registry, you can help improve safety information for medicines, which enables informed decision-making by healthcare providers and pregnant women in the future.

For the latest important safety information, please refer to the full Prescribing Information and Patient Information. This is not intended to replace discussions with your healthcare provider.

This site uses cookies including for the essential functioning of the site and for analytical purposes.

For more information about these cookies and the choices you have to manage them, please view our Privacy Policy or visit the Interactive Advertising Bureau.

By clicking through the website, we understand this means you have accepted our cookies.